CLINICAL ROLE -
Christian Ruff, MD, MPH, is director of general cardiology at Brigham and Women's Hospital.
New Data Highlights Abelacimab’s Safety Advantage in Atrial Fibrillation
Christian Ruff, MD, highlights abelacimab’s potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.
Read More
Expert: Pharmacists Play Key Role in Abelacimab Adoption, Adherence as Data Shows Promise in Atrial Fibrillation
Pharmacists should educate patients on abelacimab's potential therapeutic impact on atrial fibrillation patients at risk of stroke.
Expert: Abelacimab Shows Significant Bleeding Reduction, Offering Safer Option for Atrial Fibrillation Treatment
Christian Ruff explains the strong efficacy associated with abelacimab compared with rivaroxaban in the AZALEA-TIMI 71 trial.